Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to the Bonhawa High Flow Oxygen Therapy system for patients with respiratory ...

IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., a technology leader in the respiratory industry, announced today that it has received FDA clearance to market its Bonhawa High Flow Oxygen Therapy ...

In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve survival compared with standard oxygen. However, high-flow oxygen did ...

Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.

SAN FRANCISCO -- Starting high-flow oxygen right away for young children with acute hypoxemic respiratory failure didn't help them leave the hospital sooner than standard oxygen therapy, the PARIS-2 ...

Please provide your email address to receive an email when new articles are posted on . Children aged 1 to 4 years with acute hypoxemic respiratory failure did not experience shorter hospital stays on ...

High Flow Oxygen Therapy Market Overview: The high flow oxygen therapy (HFOT) market is expected to expand at a compound annual growth rate (CAGR) of approximately 7% during the forecast period. This ...

"High Flow Oxygen Therapy Devices Market"The global high-flow oxygen therapy devices market is estimated to grow at a CAGR of 2.31% during the forecast period from 2025 to 2032. The global High-Flow ...

High-flow oxygen didn't help patients survive acute hypoxemic respiratory failure better than standard oxygen, the SOHO trial showed. Mortality at day 28 came out an identical 14.6% in patients ...

IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., an innovator of next generation respiratory technology, announced today that it has received CE (Conformité Européenne) Marking under the European ...